Archive

Competition from “skinny label” generics saved Medicare billions

Written by | 30 Apr 2024

An analysis of 15 name-brand drugs and their “skinny label” generic counterparts found that competition from these counterparts saved Medicare Part D nearly $15 billion from 2015 to […]

Drug-pricing program improved prostate cancer treatment adherence

Written by | 26 Mar 2024

Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at […]

One in five state Medicaid programs covers weight loss medications

Written by | 18 Mar 2024

Mounting evidence suggests that FDA-approved weight loss medications, such as Wegovy, not only help patients lose weight but also protect against complications from obesity such as cardiovascular disease. […]

Mark Cuban Drug Company may offer savings for urology drugs

Written by | 27 Feb 2024

 An online pharmacy offering standardized, transparent pricing can reduce out-of-pocket costs for patients taking common medications prescribed by urologists, suggests a study in the March issue of Urology Practice®, an […]

New prescription drugs typically sold first in US

Written by | 7 Feb 2024

Most new prescription drugs are sold first in the U.S. before they reach other nations, but ultimately important medications are sold across most wealthy nations within about a […]

Out-of-pocket cost increase could put HIV prevention medications out of reach

Written by | 10 Jan 2024

Increasing patients’ out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a […]

Medicare is overpaying for generic drugs

Written by | 8 Dec 2023

Medicare is the single largest provider of health insurance in the United States, serving 63.8 million senior citizens as of 2022. Three-quarters of these recipients are enrolled in […]

Pharmacy forecast identifies growing societal challenges expected to impact care

Written by | 6 Dec 2023

Societal issues — including the growth in ultra-high-cost treatments, the epidemic of mental health and substance use disorders, climate change, and the rise of artificial intelligence (AI)— could […]

Patient support programs for prescription drugs are common, especially for expensive drugs

Written by | 30 Nov 2023

About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing and educational supports. […]

Cheap medicines prevented migraine as well as expensive ones

Written by | 21 Nov 2023

Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity. Chronic migraine can be disabling and may prevent […]

Drug manufacturers use FDA, patent strategies to keep insulin prices high

Written by | 18 Nov 2023

Over the last four decades, insulin manufacturers have extended their periods of market exclusivity on brand-name insulin products by employing several strategies, including filing additional patents on their […]

Americans will spend half their lives taking prescription drugs, study finds

Written by | 18 Oct 2023

An American born in 2019 will spend a larger share of their lifetime taking prescription drugs than being married or receiving an education, according to new research by […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.